These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 16127948)

  • 1. Integrating risk history screening and HCV testing into clinical and public health settings.
    Alter MJ
    Am Fam Physician; 2005 Aug; 72(4):576, 579. PubMed ID: 16127948
    [No Abstract]   [Full Text] [Related]  

  • 2. Screening for HCV infection: understanding the USPSTF recommendation.
    Randhawa GS; Calonge N
    Am Fam Physician; 2005 Aug; 72(4):579-80. PubMed ID: 16127949
    [No Abstract]   [Full Text] [Related]  

  • 3. Validation of a hepatitis C screening tool in primary care.
    McGinn T; O'Connor-Moore N; Alfandre D; Gardenier D; Wisnivesky J
    Arch Intern Med; 2008 Oct; 168(18):2009-13. PubMed ID: 18852403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis C: a public health response in Kansas.
    Taylor C; Waters K
    Kans Nurse; 2004 Apr; 79(4):8-9. PubMed ID: 16381345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcome of screening for hepatitis C virus infection based on risk factors.
    Mallette C; Flynn MA; Promrat K
    Am J Gastroenterol; 2008 Jan; 103(1):131-7. PubMed ID: 17894850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening campaign of hepatitis C among underprivileged people consulting in health centres of Lyon area, France.
    Sahajian F; Vanhems P; Bailly F; Fabry J; Trepo C; Sepetjan M
    Eur J Public Health; 2007 Jun; 17(3):263-71. PubMed ID: 17068003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis C virus (HCV).
    Berk PD
    Semin Liver Dis; 2000; 20(1):iii-v. PubMed ID: 10895427
    [No Abstract]   [Full Text] [Related]  

  • 8. Hepatitis C and general practice: the challenge continues.
    Kidd M
    Aust Fam Physician; 2003 Oct; 32(10):795. PubMed ID: 14596072
    [No Abstract]   [Full Text] [Related]  

  • 9. [Serological and molecular markers of HCV infection in Polish blood donors].
    Brojer E
    Przegl Epidemiol; 2005; 59(2):511-7. PubMed ID: 16190561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An evidence of high prevalence of Hepatitis C virus in Faisalabad, Pakistan.
    Ahmad N; Asgher M; Shafique M; Qureshi JA
    Saudi Med J; 2007 Mar; 28(3):390-5. PubMed ID: 17334466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis C virus (HCV): a silent epidemic.
    Bandy U
    Med Health R I; 1999 Jun; 82(6):223-4. PubMed ID: 10402843
    [No Abstract]   [Full Text] [Related]  

  • 12. Modelling the force of infection for hepatitis B and hepatitis C in injecting drug users in England and Wales.
    Sutton AJ; Gay NJ; Edmunds WJ; Hope VD; Gill ON; Hickman M
    BMC Infect Dis; 2006 Jun; 6():93. PubMed ID: 16762050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [HCV genotypes in Polish blood donors in period 1995-2007].
    Brojer E; Grabarczyk P; Kopacz A; Potepa A; Medyńska J; Smolarczyk-Wodzyńska J; Letowska M
    Przegl Epidemiol; 2008; 62(1):163-9. PubMed ID: 18536240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Health care worker-to-patient transmission of hepatitis C virus in the health care setting: Many questions and few answers.
    Raggam RB; Rossmann AM; Salzer HJ; Stauber RE; Kessler HH
    J Clin Virol; 2009 Aug; 45(4):272-5. PubMed ID: 19477680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prevalence of hepatitis C virus markers in Polish blood donors in 1994-2003].
    Seyfried H; Brojer E; Grabarczyk P; Rosińska M; Gronowska A; Letowska M;
    Przegl Epidemiol; 2005; 59(4):807-14. PubMed ID: 16729421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A multi-Chinese blood center study testing serologic-negative donor samples for hepatitis C virus and human immunodeficiency virus with nucleic acid testing.
    Shan H; Ren FR; Zhao HY; Zhang YZ; Wen GX; Yao FZ; Gao GJ; Yan LX; Jiang CF; Bai XH; Tiemuer MH; Tu YQ; Zhu FM; Zheng YR; Cui L; Liu CL; Gong XY; Lv QS; Zheng P; Ziermann R; Ness P; Wang JX
    Transfusion; 2007 Nov; 47(11):2011-6. PubMed ID: 17958529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Travel-associated acquisition of hepatitis C virus infection in patients receiving haemodialysis.
    Ghafur A; Raza M; Labbett W; Chawla A; Smith C; Ngui SL; Davenport A; Geretti AM
    Nephrol Dial Transplant; 2007 Sep; 22(9):2640-4. PubMed ID: 17535845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimation of delay in detecting hepatitis C virus antibodies in pools compared to individual testing on seroconversion panels.
    Sarov B; Novack L; Galai N; Yaari A; Orgel M; Safi J; Yahalom V; Shinar E
    Clin Microbiol Infect; 2007 Jul; 13(7):737-9. PubMed ID: 17441976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hepatitis C in Poland in 2006].
    Bobel D; Rosińska M
    Przegl Epidemiol; 2008; 62(2):325-32. PubMed ID: 18807475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiology of HCV infection in the general population: a survey in a southern Italian town.
    Cozzolongo R; Osella AR; Elba S; Petruzzi J; Buongiorno G; Giannuzzi V; Leone G; Bonfiglio C; Lanzilotta E; Manghisi OG; Leandro G; ; Donnaloia R; Fanelli V; Mirizzi F; Parziale L; Crupi G; Detomaso P; Labbate A; Zizzari S; Depalma M; Polignano A; Lopinto D; Daprile G
    Am J Gastroenterol; 2009 Nov; 104(11):2740-6. PubMed ID: 19638964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.